In our study, the anticoagulants analyzed were direct thrombin inhibitor, factor Xa inhibitors, as well as warfarin, and whether the new oral anticoagulants could have a role in preventing MI in the setting of AF needs to be further investigated. The gene discussed is F10; the disease is atrial fibrillation.